image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 13.24
-2.5 %
$ 2.63 B
Market Cap
-2.96
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one XRAY stock under the worst case scenario is HIDDEN Compared to the current market price of 13.2 USD, DENTSPLY SIRONA Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one XRAY stock under the base case scenario is HIDDEN Compared to the current market price of 13.2 USD, DENTSPLY SIRONA Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one XRAY stock under the best case scenario is HIDDEN Compared to the current market price of 13.2 USD, DENTSPLY SIRONA Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart XRAY

image
$26.0$26.0$24.0$24.0$22.0$22.0$20.0$20.0$18.0$18.0$16.0$16.0$14.0$14.0$12.0$12.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
3.79 B REVENUE
-4.34%
-879 M OPERATING INCOME
-934.12%
-910 M NET INCOME
-589.39%
461 M OPERATING CASH FLOW
22.28%
-197 M INVESTING CASH FLOW
-121.35%
-302 M FINANCING CASH FLOW
1.63%
905 M REVENUE
-4.84%
-509 M OPERATING INCOME
-10.17%
-428 M NET INCOME
13.54%
87 M OPERATING CASH FLOW
-38.30%
-57 M INVESTING CASH FLOW
-21.28%
-38 M FINANCING CASH FLOW
51.90%
Balance Sheet DENTSPLY SIRONA Inc.
image
Current Assets 1.75 B
Cash & Short-Term Investments 272 M
Receivables 556 M
Other Current Assets 918 M
Non-Current Assets 4.01 B
Long-Term Investments 0
PP&E 902 M
Other Non-Current Assets 3.1 B
4.73 %9.66 %15.96 %15.68 %53.97 %Total Assets$5.8b
Current Liabilities 1.59 B
Accounts Payable 241 M
Short-Term Debt 549 M
Other Current Liabilities 799 M
Non-Current Liabilities 2.22 B
Long-Term Debt 1.68 B
Other Non-Current Liabilities 544 M
6.33 %14.41 %20.97 %44.02 %14.28 %Total Liabilities$3.8b
EFFICIENCY
Earnings Waterfall DENTSPLY SIRONA Inc.
image
Revenue 3.79 B
Cost Of Revenue 1.84 B
Gross Profit 1.96 B
Operating Expenses 2.84 B
Operating Income -879 M
Other Expenses 31 M
Net Income -910 M
4b4b4b4b3b3b3b3b2b2b2b2b1b1b500m500m00(500m)(500m)(1b)(1b)4b(2b)2b(3b)(879m)(31m)(910m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
51.62% GROSS MARGIN
51.62%
-23.17% OPERATING MARGIN
-23.17%
-23.99% NET MARGIN
-23.99%
-46.86% ROE
-46.86%
-15.82% ROA
-15.82%
-18.13% ROIC
-18.13%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis DENTSPLY SIRONA Inc.
image
600m600m500m500m400m400m300m300m200m200m100m100m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -910 M
Depreciation & Amortization 349 M
Capital Expenditures -180 M
Stock-Based Compensation 39 M
Change in Working Capital 95 M
Others 1.03 B
Free Cash Flow 281 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets DENTSPLY SIRONA Inc.
image
Wall Street analysts predict an average 1-year price target for XRAY of $26 , with forecasts ranging from a low of $19 to a high of $32 .
XRAY Lowest Price Target Wall Street Target
19 USD 43.50%
XRAY Average Price Target Wall Street Target
26 USD 96.37%
XRAY Highest Price Target Wall Street Target
32 USD 141.69%
Price
Max Price Target
Min Price Target
Average Price Target
32323030282826262424222220201818161614141212May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
0.82% DIVIDEND YIELD
0.16 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
0.70000.70000.60000.60000.50000.50000.40000.40000.30000.30000.20000.20000.10000.10000.00000.00000.0720.07750.08750.08750.08750.10.10.1250.140.160.160.07250.07750.08750.08750.08750.10.110.1250.140.160.07250.07750.08750.08750.10.10.110.1250.140.160.07250.290.07750.310.08750.350.08750.350.10.380.10.400.110.430.1250.500.140.560.160.640.162015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 11
6. Ownership
Insider Ownership DENTSPLY SIRONA Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
250 K USD 1
0-3 MONTHS
421 K USD 2
3-6 MONTHS
200 K USD 1
6-9 MONTHS
100 K USD 1
9-12 MONTHS
7. News
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation NEW YORK, NY / ACCESS Newswire / April 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 2 weeks ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect NEW YORK, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 2 weeks ago
Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 2 weeks ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Investors to Learn More About the Investigation NEW YORK, NY / ACCESS Newswire / March 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 3 weeks ago
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Reach Out NEW YORK, NY / ACCESS Newswire / March 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 3 weeks ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Connect NEW YORK, NY / ACCESS Newswire / March 23, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 4 weeks ago
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 1 month ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Stockholders to Learn More About the Investigation NEW YORK, NY / ACCESS Newswire / March 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 1 month ago
Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader CHARLOTTE, N.C., March 17, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (XRAY) today announced that David Ferguson has been appointed Senior Vice President, Global Business Unit Leader, effective March 14, 2025. In this role he will lead the global business unit teams managing the dental product portfolio, serve as a member of the Executive Management Team and report directly to Chief Executive Officer, Simon Campion. globenewswire.com - 1 month ago
Europe Dental Imaging Device Market Analysis 2025-2031, with Focus on Key Market Leaders including Dentsply Sirona, Carestream Dental, 3Shape and more Dublin, March 17, 2025 (GLOBE NEWSWIRE) -- The "Dental Imaging Device Market Size, Share & Trends Analysis | Europe | 2025-2031 | MedSuite | Includes: Intraoral X-Ray Imaging Equipment Market, Extraoral X-ray Imaging Market, and 3 more" report has been added to ResearchAndMarkets.com's offering. globenewswire.com - 1 month ago
Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Shareholders to Inquire about Securities Investigation NEW YORK, NY / ACCESS Newswire / March 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com - 1 month ago
Dental Burs Market Trends Analysis Report 2025-2030, with Profiles of Dentsply Sirona, Coltene, Shofu, MANI, Brasseler USA, American Orthodontics, Prima Dental, Diatech, Komet Dental & Envista Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "Dental Burs Market Size, Share & Trends Analysis Report by Material (Diamond Burs, Stainless Steel, Carbide), Application (Oral Surgery, Implantology, Orthodontics), End-Use (Hospitals, Dental Clinics), and Region with Growth Forecasts, 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Dental Burs Market was valued at USD 640.1 million in 2024, and is projected to reach USD 881.6 million by 2030, rising at a CAGR of 5.50%. The increasing prevalence of oral conditions in developed and developing countries is expected to propel the market's growth. Moreover, the growing accessibility of oral care in developing countries owing to the awareness campaigns and initiatives is expected to contribute to the market growth over the forecast period. For instance, the Oral Health Foundation is celebrating National Smile Month from 15 May to 15 June 2023 to raise awareness regarding oral health conditions globally. Dental caries or tooth decay is the most prevalent oral health condition and remains untreated. These oral health conditions can be treated with non-invasive methods if identified early. According to the FDI World Dental Federation, around 3.5 billion individuals globally suffered from oral diseases in 2020, and around 2.3 billion individuals were estimated to suffer from tooth decay in 2020. The high prevalence of tooth decay can be due to the factors such as changing lifestyles, high sugar consumption, and less awareness about oral hygiene in low- and middle-income countries. Hence, the demand for dental procedures is rising with the increasing prevalence of oral conditions in the geriatric population globally. According to the article published in PubMed Central in March 2022, the prevalence of tooth decay in the geriatric population was around 49% globally. Periodontal disease, root caries, and xerostomia are oral diseases that primarily affect the elderly population. Even though these conditions affecting the geriatric population are preventable or treatable, many do not receive the necessary treatment. Dental Burs Market Report Highlights globenewswire.com - 1 month ago
8. Profile Summary

DENTSPLY SIRONA Inc. XRAY

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 2.63 B
Dividend Yield 0.82%
Description DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
Contact 13320 Ballantyne Corporate Place, Charlotte, NC, 28277-3607 https://www.dentsplysirona.com
IPO Date Aug. 12, 1987
Employees 14000
Officers Mr. Richard C. Rosenzweig J.D. Executive Vice President of Corporate Development, General Counsel & Secretary Mr. Kevin Boyle Senior Vice President & Chief Technology Officer Mr. Kevin Czerney Vice President & Chief Accounting Office Mr. David Ferguson Senior Vice President of Global Business Unit Leader Ms. Emily P. Miner Senior Vice President of Global Quality and Regulatory & Chief Quality Officer Mr. Robert Anthony Johnson Senior Vice President & Chief Supply Chain Officer and Head of Sustainability Ms. Andrea L. Frohning Senior Vice President & Chief Human Resources Officer Ms. Andrea Daley Vice President of Investor Relations Mr. Simon D. Campion Chief Executive Officer, President & Director Mr. Herman V. Cueto Interim Chief Financial Officer